TY - JOUR
T1 - Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant β-catenin
AU - Nejak-Bowen, Kari N.
AU - Thompson, Michael D.
AU - Singh, Sucha
AU - Bowen, William C.
AU - Dar, Mohd Jamal
AU - Khillan, Jaspal
AU - Dai, Chunsun
AU - Monga, Satdarshan P.S.
PY - 2010/5
Y1 - 2010/5
N2 - The Wnt/β-catenin pathway is implicated in the pathogenesis of hepatocellular cancer (HCC). We developed a transgenic mouse (TG) in the FVB strain that overexpresses Ser45-mutated-β-catenin in hepatocytes to study the effects on liver regeneration and cancer. In the two independent TG lines adult mice show elevated β-catenin at hepatocyte membrane with no increase in the Wnt pathway targets cyclin-D1 or glutamine synthetase. However, TG hepatocytes upon culture exhibit a 2-fold increase in thymidine incorporation at day 5 (D5) when compared to hepatocytes from wildtype FVB mice (WT). When subjected to partial hepatectomy (PH), dramatic increases in the number of hepatocytes in S-phase are evident in TG at 40 and WTat 72 hours. Coincident with the earlier onset of proliferation, we observed nuclear translocation of β-catenin along with an increase in total and nuclear cyclin-D1 protein at 40 hours in TG livers. To test if stimulation of β-catenin induces regeneration, we used hydrodynamic delivery of Wnt-1 naked DNA to control mice, which prompted an increase in Wnt-1, β-catenin, and known targets, glutamine synthetase (GS) and cyclin-D1, along with a concomitant increase in cell proliferation. β-Catenin-overexpressing TG mice, when followed up to 12 months, showed no signs of spontaneous tumorigenesis. However, intraperitoneal delivery of diethylnitrosamine (DEN), a known carcinogen, induced HCC at 6 months in TG mice only. Tumors in TG livers showed upregulation of β-catenin, cyclin-D1, and unique genetic aberrations, whereas other canonical targets were unremarkable. Conclusion: β-Catenin overexpression offers growth advantage during liver regeneration. Also, whereas no spontaneous HCC is evident, β-catenin overexpression makes TG mice susceptible to DEN-induced HCC.
AB - The Wnt/β-catenin pathway is implicated in the pathogenesis of hepatocellular cancer (HCC). We developed a transgenic mouse (TG) in the FVB strain that overexpresses Ser45-mutated-β-catenin in hepatocytes to study the effects on liver regeneration and cancer. In the two independent TG lines adult mice show elevated β-catenin at hepatocyte membrane with no increase in the Wnt pathway targets cyclin-D1 or glutamine synthetase. However, TG hepatocytes upon culture exhibit a 2-fold increase in thymidine incorporation at day 5 (D5) when compared to hepatocytes from wildtype FVB mice (WT). When subjected to partial hepatectomy (PH), dramatic increases in the number of hepatocytes in S-phase are evident in TG at 40 and WTat 72 hours. Coincident with the earlier onset of proliferation, we observed nuclear translocation of β-catenin along with an increase in total and nuclear cyclin-D1 protein at 40 hours in TG livers. To test if stimulation of β-catenin induces regeneration, we used hydrodynamic delivery of Wnt-1 naked DNA to control mice, which prompted an increase in Wnt-1, β-catenin, and known targets, glutamine synthetase (GS) and cyclin-D1, along with a concomitant increase in cell proliferation. β-Catenin-overexpressing TG mice, when followed up to 12 months, showed no signs of spontaneous tumorigenesis. However, intraperitoneal delivery of diethylnitrosamine (DEN), a known carcinogen, induced HCC at 6 months in TG mice only. Tumors in TG livers showed upregulation of β-catenin, cyclin-D1, and unique genetic aberrations, whereas other canonical targets were unremarkable. Conclusion: β-Catenin overexpression offers growth advantage during liver regeneration. Also, whereas no spontaneous HCC is evident, β-catenin overexpression makes TG mice susceptible to DEN-induced HCC.
UR - http://www.scopus.com/inward/record.url?scp=77951487860&partnerID=8YFLogxK
U2 - 10.1002/hep.23538
DO - 10.1002/hep.23538
M3 - Article
C2 - 20432254
AN - SCOPUS:77951487860
VL - 51
SP - 1603
EP - 1613
JO - Hepatology
JF - Hepatology
SN - 0270-9139
IS - 5
ER -